![]() ![]() District Court for the Northern District of Florida.Plaintiffs Richard F. Cases are consolidated in this way in federal court since it is a more efficient and effective way of handling claims, and it provides plaintiffs with a greater chance to receive a substantial financial compensation.Ĭurrently, almost 400 suits have been centralized in the MDL No. The purpose of an MDL is to speed up the discovery phase and other pretrial proceedings. Instead, since multiple lawsuits have been filed against the manufacturers alleging similar injuries and other damages caused by this products, they have been centralized in a multidistrict litigation (MDL). ![]() To date, most attorneys are doubtful that this type of litigation will be certified for patients who are adversely affected by the drug. There is no Abilify class action pending as of December, 2017. Is the Abilify Litigation a Class Action or a Mass Tort Action? However, failure to warn of side effects of a drug can be a basis of a defective product liability, regardless of whether the medicine has been recalled or not. Children, teenagers, and young adults who take antidepressants to treat depression or other mental illnesses may be more likely to become suicidal than children, teenagers, and young adults who do not take antidepressants to treat these conditions.Īlthough the FDA has issued a Safety Alert to warn patients about its potential risks, there has not been an Abilify recall, yet.Īlthough many lawyers claim that the drug makers failed to disclose known side effects of the medication which severely harmed patients as a result, none of these adverse reactions forced the pharmaceutical companies to withdraw it from the market. People who have depression and take antipsychotics are especially warned that a small number of children, teenagers, and young adults (up to 24 years of age) who took medications for depression during clinical studies became suicidal. It is also noted that the FDA has not approved Aripiprazole for the treatment of behavior problems in older adults with dementia. Older adults with dementia may also have a greater chance of having a stroke or ministroke or other severe side effects during treatment. According to the NIH’s drug information, studies reportedly show that older adults with dementia who take antipsychotics, including Abilify, have an increased chance of death during treatment. ![]() In addition to the alleged relationship between the use of Abilify and compulsive behaviors, there are a number of other risks associated with the prescription antipsychotic. label for the drug did not contain any mention of these issues prior to January 2016, however. Food and Drug Administration (FDA) released a safety communication to alert the public about reported instances of compulsive urges, with the use of Abilify. However, they willingly failed to report these risks in the United States, as the label for the medication in Europe and Canada was already required to include such warnings. Plaintiffs claim that drug makers Bristol-Myers Squibb and Otsuka Pharmaceutical knew, or should have known, that the drug could lead to an increased risk of uncontrollable compulsive behaviors. Numerous clinical studies reported a strong association between the use of this drug and the development of serious form of loss of impulse control. These serious side effects have resulted in substantial financial, mental and physical damages to patients who have taken the drug.Ĭompulsive gambling is a major psychiatric disorder, first recognized in the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders (DSM) in 1980. The antipsychotic medication Abilify has recently been linked to compulsive behaviors including gambling, shopping, hypersexuality, and loss of impulse control. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |